(CLMT) Calumet Specialty Products - Ratings and Ratios
Specialty Lubricants, Base Oils, Solvents, Asphalt, Wax
CLMT EPS (Earnings per Share)
CLMT Revenue
Description: CLMT Calumet Specialty Products
Calumet Specialty Products Partners (NASDAQ:CLMT) is a US-based company operating in the Oil & Gas Refining & Marketing sub-industry. The companys quarterly tax provision is a crucial aspect of its financials, influencing its overall profitability.
To evaluate CLMTs performance, key performance indicators (KPIs) such as revenue growth, EBITDA margins, and debt-to-equity ratio are essential. The companys ability to manage its tax provision effectively can significantly impact its bottom line. A thorough analysis of CLMTs tax provision would involve examining its historical tax rates, deferred tax assets, and liabilities to understand potential future implications.
Key economic drivers for CLMT include crude oil prices, refining margins, and demand for petroleum products. Fluctuations in these drivers can significantly impact the companys revenue and profitability. Additionally, regulatory changes, such as those related to environmental policies, can also affect CLMTs operations and financials.
From a valuation perspective, CLMTs market capitalization and forward P/E ratio suggest that the market is pricing in expectations for the companys future performance. A detailed analysis of CLMTs financial statements, including its income statement, balance sheet, and cash flow statement, would provide further insights into its financial health and potential for future growth.
CLMT Stock Overview
| Market Cap in USD | 1,201m |
| Sub-Industry | Oil & Gas Refining & Marketing |
| IPO / Inception | 2006-01-26 |
CLMT Stock Ratings
| Growth Rating | 27.8% |
| Fundamental | 20.7% |
| Dividend Rating | 11.7% |
| Return 12m vs S&P 500 | -22.8% |
| Analyst Rating | 3.86 of 5 |
CLMT Dividends
Currently no dividends paidCLMT Growth Ratios
| Growth Correlation 3m | 7.7% |
| Growth Correlation 12m | -60.7% |
| Growth Correlation 5y | 63.4% |
| CAGR 5y | 45.13% |
| CAGR/Max DD 5y | 0.73 |
| Sharpe Ratio 12m | -0.06 |
| Alpha | -39.06 |
| Beta | 1.790 |
| Volatility | 54.83% |
| Current Volume | 518.3k |
| Average Volume 20d | 713.9k |
| Stop Loss | 15.3 (-6.1%) |
| Signal | 0.12 |
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income (-451.2m TTM) > 0 and > 6% of Revenue (6% = 244.2m TTM) |
| FCFTA -0.04 (>2.0%) and ΔFCFTA 6.30pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -6.88% (prev -9.95%; Δ 3.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.05 (>3.0%) and CFO -126.9m > Net Income -451.2m (YES >=105%, WARN >=100%) |
| Net Debt (121.2m) to EBITDA (7.70m) ratio: 15.74 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (86.8m) change vs 12m ago 7.75% (target <= -2.0% for YES) |
| Gross Margin -0.90% (prev -10.83%; Δ 9.93pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 149.4% (prev 159.7%; Δ -10.27pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.54 (EBITDA TTM 7.70m / Interest Expense TTM 230.5m) >= 6 (WARN >= 3) |
Altman Z'' -3.69
| (A) -0.10 = (Total Current Assets 895.8m - Total Current Liabilities 1.18b) / Total Assets 2.78b |
| (B) -0.67 = Retained Earnings (Balance) -1.85b / Total Assets 2.78b |
| (C) -0.05 = EBIT TTM -125.2m / Avg Total Assets 2.72b |
| (D) -0.52 = Book Value of Equity -1.85b / Total Liabilities 3.54b |
| Total Rating: -3.69 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 20.70
| 1. Piotroski 0.0pt = -5.0 |
| 2. FCF Yield -3.53% = -1.76 |
| 3. FCF Margin -3.02% = -1.13 |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda 311.4 = -2.50 |
| 6. ROIC - WACC -14.35% = -12.50 |
| 7. RoE data missing |
| 8. Rev. Trend -31.18% = -1.56 |
| 9. Rev. CAGR -4.49% = -0.75 |
| 10. EPS Trend -63.75% = -1.59 |
| 11. EPS CAGR -137.5% = -2.50 |
What is the price of CLMT shares?
Over the past week, the price has changed by +2.19%, over one month by -0.79%, over three months by +13.19% and over the past year by -9.75%.
Is Calumet Specialty Products a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CLMT is around 18.29 USD . This means that CLMT is currently undervalued and has a potential upside of +12.21% (Margin of Safety).
Is CLMT a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CLMT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.1 | 16.9% |
| Analysts Target Price | 19 | 16.6% |
| ValueRay Target Price | 19.8 | 21.7% |
Last update: 2025-08-22 02:47
CLMT Fundamental Data Overview
CCE Cash And Equivalents = 110.6m USD (Cash And Short Term Investments, last quarter)
P/E Forward = 11.3507
P/S = 0.295
P/B = 19.3228
P/EG = 2.71
Beta = 0.911
Revenue TTM = 4.07b USD
EBIT TTM = -125.2m USD
EBITDA TTM = 7.70m USD
Long Term Debt = 2.11b USD (from longTermDebt, last quarter)
Short Term Debt = 292.1m USD (from shortTermDebt, last quarter)
Debt = 2.40b USD (Calculated: Short Term 292.1m + Long Term 2.11b)
Net Debt = 121.2m USD (from netDebt column, last quarter)
Enterprise Value = 3.49b USD (1.20b + Debt 2.40b - CCE 110.6m)
Interest Coverage Ratio = -0.54 (Ebit TTM -125.2m / Interest Expense TTM 230.5m)
FCF Yield = -3.53% (FCF TTM -123.1m / Enterprise Value 3.49b)
FCF Margin = -3.02% (FCF TTM -123.1m / Revenue TTM 4.07b)
Net Margin = -11.08% (Net Income TTM -451.2m / Revenue TTM 4.07b)
Gross Margin = -0.90% ((Revenue TTM 4.07b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Tobins Q-Ratio = -1.88 (set to none) (Enterprise Value 3.49b / Book Value Of Equity -1.85b)
Interest Expense / Debt = 2.21% (Interest Expense 52.9m / Debt 2.40b)
Taxrate = 21.0% (US default)
NOPAT = -125.2m (EBIT -125.2m, no tax applied on loss)
Current Ratio = 0.76 (Total Current Assets 895.8m / Total Current Liabilities 1.18b)
Debt / EBITDA = 311.4 (Net Debt 121.2m / EBITDA 7.70m)
Debt / FCF = -19.48 (Debt 2.40b / FCF TTM -123.1m)
Total Stockholder Equity = -814.0m (last 4 quarters mean)
RoA = -16.25% (Net Income -451.2m, Total Assets 2.78b )
RoE = unknown (Net Income TTM -451.2m / Total Stockholder Equity -814.0m)
RoCE = -9.69% (Ebit -125.2m / (Equity -814.0m + L.T.Debt 2.11b))
RoIC = -8.98% (NOPAT -125.2m / Invested Capital 1.39b)
WACC = 5.37% (E(1.20b)/V(3.60b) * Re(12.61%)) + (D(2.40b)/V(3.60b) * Rd(2.21%) * (1-Tc(0.21)))
Shares Correlation 5-Years: 100.0 | Cagr: 2.37%
Discount Rate = 12.61% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -123.1m)
Revenue Correlation: -31.18 | Revenue CAGR: -4.49%
Rev Growth-of-Growth: -3.28
EPS Correlation: -63.75 | EPS CAGR: -137.5%
EPS Growth-of-Growth: -98.43
Additional Sources for CLMT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle